About Natco Pharma Limited
Data last updated:
Natco Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the fertilizers and soil enhancers segment of the agriculture sector. It was incorporated on 19 September 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L24230TG1981PLC003201. Its GSTIN is 36AAACN6927A1ZQ (Telangana). The company holds 32 GST registrations, of which 25 are active. Its shares are listed on BSE: 524816 and NSE: NATCOPHARM.
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹35.82 Cr. It was formerly known as Natco Fine Pharmaceuticals Private Limited. It is led by directors including Venkaiah Chowdary Nannapaneni (Managing Director) and Potluri Prasad Sivaramakrishna (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Natco House Road No.2 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹4,784 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1,883.4 Cr (net margin 39.4%) and EBITDA of ₹2,550.5 Cr (EBITDA margin 53.3%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 19% over five years.
The company has about 4,652 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Natco Pharma. As per MCA filings, the company has open charges of ₹1,120 Cr and satisfied charges of ₹1,277.71 Cr on record. Court records list 297 cases involving the company, including 147 filed by the company and 104 filed against it; 70 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website natcopharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNatco House Road No.2 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryAgriculture, Fertilizers & Soil Enhancers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Natco Pharma Limited
Natco Pharma has one previous CIN (Corporate Identification Number): L24230AP1981PLC003201. The current CIN is L24230TG1981PLC003201, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230TG1981PLC003201 | Current |
| L24230AP1981PLC003201 | Previous |
Associated Brands with Natco Pharma Limited
Natco Pharma operates one associated brand: Natco Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs and finished dosage forms are developed and manufactured. | natcopharma.co.in |
Business Activity of Natco Pharma Limited
The main business activity of Natco Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Natco Pharma Limited
Natco Pharma Limited is audited by B S R & Associates LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Natco Pharma Limited
Natco Pharma has 9 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Potluri Prasad Sivaramakrishna Also directs: Natco Crop Health Sciences Limited | Whole-Time Director | 12 Nov 2014 | 11 Years 10 Months | Current |
| Lingarao Donthineni | Whole-Time Director | 11 Feb 2015 | 11 Years 7 Months | Current |
| Venkaiah Chowdary Nannapaneni | Managing Director | 01 Apr 2015 | 11 Years 6 Months | Current |
| Rajeev Nannapaneni Also directs: Natco Aqua Limited, Natsoft Information Systems Private Limited, L V P Eye Innovations Foundation and 1 more | Whole-Time Director | 01 Jun 2012 | 14 Years 4 Months | Current |
| Nitin Jain Also directs: Amanta Healthcare Limited | Director | 12 Aug 2024 | 2 Years 1 Months | Current |
| Suma Kantipudi Also directs: Prasad Property Management Private Limited, HSRL Enterprises Private Limited, Melite Soft Technologies Private Limited and 3 more | Director | 12 Aug 2024 | 2 Years 1 Months | Current |
Financials of Natco Pharma Limited FY 2025 filings available
Natco Pharma Limited reported revenue of ₹4,784 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Natco Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 16% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Natco Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2,550.5 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,883.4 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Natco Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 53.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 39.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Natco Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Natco Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Natco Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2025 | State Bank of India | ₹600 Cr | Open |
| 08 Mar 2011 | Others | ₹520 Cr | Open |
| 18 Oct 2016 | Others | ₹50 Cr | Satisfied |
| 22 Jun 2015 | Citi Bank N.A. | ₹12.05 Cr | Satisfied |
| 22 Dec 2014 | Citi Bank N.A. | ₹60 Cr | Satisfied |
Total charge records: 58 View all charges
Employees and EPFO Compliance at Natco Pharma Limited
Natco Pharma Limited has a workforce of 4,652 employees as of Aug 26, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Natco Pharma Limited
Natco Pharma has 32 GST registrations: 25 active and 7 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACN6927A1ZQ | Telangana | Active | 01 Jul 2017 |
| 36AAACN6927A2ZP | Telangana | Active | 01 Jan 2018 |
| 36AAACN6927A3ZO | Telangana | Active | 17 Oct 2019 |
| 05AAACN6927A1ZV | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Natco Pharma Limited
Natco Pharma Limited has 297 court cases on record: 147 filed by Natco Pharma, 104 filed against it, 46 where it is another party. 70 cases are pending and 227 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 180 | 61 | 30 |
| District courts | 104 | 40 | 39 |
| Supreme Court | 13 | 3 | 1 |
Cases on record (5 of 297)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Rallis India Limited | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against Aggarsain Agropest Private Limited | Pending |
| High Court for State of Telangana | Arbitration matter | Filed against the company by Sparkvee Fine Chemicals Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (COP) | Filed against the company by Sparkvee Fine Chemicals Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (COP) | Filed by the company against Sparkvee Fine Chemicals Private Limited | Disposed |
Full case history
All 297 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Natco Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Natco Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Natco Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Natco Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Natco Pharma Limited
Recent News on Natco Pharma Limited
Frequently Asked Questions about Natco Pharma Limited
Natco Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in fertilizers and soil enhancers, within the agriculture industry. It was incorporated on 19 September 1981 (45+ years old) and is registered under CIN L24230TG1981PLC003201. Listed on BSE: 524816 and NSE: NATCOPHARM.
Natco Pharma reported revenue of ₹4,784 Cr for FY 2025 (up 16% YoY).
Natco Pharma has 9 current directors:
- Venkaiah Chowdary Nannapaneni - Managing Director
- Potluri Prasad Sivaramakrishna - Whole-Time Director
- Lingarao Donthineni - Whole-Time Director
- Rajeev Nannapaneni - Whole-Time Director
- Nitin Jain - Director
- Suma Kantipudi - Director
- Lakshminarayana Bolisetty - Director
- Agnihotra Dakshina Murty Chavali - Director
- Vijayabhaskar Dronadula - Director
Natco Pharma reported a net profit of ₹1,883.4 Cr (net margin 39.4%) and EBITDA of ₹2,550.5 Cr (EBITDA margin 53.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Natco Pharma is 33% over three years and 19% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Natco Pharma is 36AAACN6927A1ZQ, registered in Telangana. The company has 32 GST registrations in all, of which 25 are active and 7 are cancelled or inactive. Other active GSTINs include 36AAACN6927A2ZP (Telangana), 36AAACN6927A3ZO (Telangana), 05AAACN6927A1ZV (Uttarakhand).
The CIN (Corporate Identification Number) of Natco Pharma is L24230TG1981PLC003201. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Natco Pharma is listed on both BSE (code: 524816) and NSE (symbol: NATCOPHARM).
Natco Pharma has 297 court cases on record: 147 filed by the company and 104 filed against it. 70 are pending. Most are in the high courts.